Blood Cancer Journal

Fig. 2: Survival outcomes of patients with EMD versus no EMD. | Blood Cancer Journal

Fig. 2: Survival outcomes of patients with EMD versus no EMD.

From: Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy

Fig. 2

Search

Advanced search

Quick links